Gemmer Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-24
| Closed | -$5K | – | 1288 |
|
|
2021
Q4 | $5K | Sell |
24
-9
| -27% | -$1.88K | ﹤0.01% | 1004 |
|
|
2021
Q3 | $9K | Hold |
33
| – | – | ﹤0.01% | 747 |
|
|
2021
Q2 | $9K | Buy |
33
+13
| +65% | +$3.55K | ﹤0.01% | 839 |
|
|
2021
Q1 | $6K | Buy |
20
+2
| +11% | +$600 | ﹤0.01% | 989 |
|
|
2020
Q4 | $5K | Buy |
18
+1
| +6% | +$278 | ﹤0.01% | 988 |
|
|
2020
Q3 | $4K | Buy |
17
+1
| +6% | +$235 | ﹤0.01% | 980 |
|
|
2020
Q2 | $6K | Sell |
16
-7
| -30% | -$2.63K | ﹤0.01% | 794 |
|
|
2020
Q1 | $6K | Sell |
23
-80
| -78% | -$20.9K | ﹤0.01% | 701 |
|
|
2019
Q4 | $33K | Sell |
103
-4
| -4% | -$1.28K | 0.01% | 267 |
|
|
2019
Q3 | $29K | Buy |
107
+14
| +15% | +$3.79K | 0.01% | 290 |
|
|
2019
Q2 | $49K | Buy |
93
+77
| +481% | +$40.6K | 0.01% | 190 |
|
|
2019
Q1 | $8K | Hold |
16
| – | – | ﹤0.01% | 800 |
|
|
2018
Q4 | $8K | Sell |
16
-6
| -27% | -$3K | ﹤0.01% | 716 |
|
|
2018
Q3 | $20K | Sell |
22
-11
| -33% | -$10K | 0.01% | 405 |
|
|
2018
Q2 | $24K | Sell |
33
-1
| -3% | -$727 | 0.01% | 340 |
|
|
2018
Q1 | $53K | Buy |
34
+1
| +3% | +$1.56K | 0.02% | 175 |
|
|
2017
Q4 | $29K | Buy |
33
+2
| +6% | +$1.76K | 0.01% | 304 |
|
|
2017
Q3 | $11K | Hold |
31
| – | – | ﹤0.01% | 627 |
|
|
2017
Q2 | $9K | Hold |
31
| – | – | ﹤0.01% | 699 |
|
|
2017
Q1 | $11K | Hold |
31
| – | – | ﹤0.01% | 608 |
|
|
2016
Q4 | $6K | Hold |
31
| – | – | ﹤0.01% | 846 |
|
|
2016
Q3 | $8K | Hold |
31
| – | – | ﹤0.01% | 704 |
|
|
2016
Q2 | $7K | Buy |
31
+4
| +15% | +$903 | ﹤0.01% | 731 |
|
|
2016
Q1 | $5K | Sell |
27
-58
| -68% | -$10.7K | ﹤0.01% | 832 |
|
|
2015
Q4 | $21K | Buy |
85
+71
| +507% | +$17.5K | 0.01% | 292 |
|
|
2015
Q3 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 1106 |
|